Although the Indonesian National Tuberculosis Program (NTP) has made significant progress in case detention and treatment in recent years, Indonesia continues to be a “high-burden” country — one of 22 countries that account for approximately 80 percent of the world’s new tuberculosis (TB) cases each year.
Under the TB Care I project, funded by the U.S. Agency for International Development, FHI 360 is working with the NTP to expand recent advances in TB control to additional areas of the country. FHI 360 serves as the technical lead in supporting NTP efforts in two priority areas: (1) effective management of TB-HIV co-infection, and (2) TB control in prisons.
FHI 360 uses state-of-the-art, innovative and locally relevant approaches to support Indonesia’s TB program. The TB-CARE I project works to advance the integration of TB and HIV services, strengthen health systems to improve the quality and efficiency of service delivery in the public health system, and engage civil society organizations to support TB control at the community level. FHI 360 also is a contributing partner in other key program areas, such as surveillance, monitoring and evaluation, laboratory capacity and human resources.